Rosacea

Assess persistent centrofacial erythema, episodic flushing, telangiectasia, papules and pustules, skin thickening, and ocular symptoms at the same visit. Rosacea phenotypes commonly overlap; treating only inflammatory lesions will not reliably address fixed erythema or telangiectasia. Wiley+1WileyRosacea Management: Update on general measures and topical treatment options - Schaller - 2016 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online LibraryWolters KluwerUpdate on the Management of Rosacea : Plastic Surgical Nursing

Ask specifically about gritty or dry eyes, recurrent red eyes, burning, photophobia, fluctuating vision, and recurrent chalazia. Examine lid margins for hyperemia, telangiectasia, chronic blepharitis, and meibomian gland dysfunction; these findings favor ocular rosacea in a patient with compatible facial disease. Wolters KluwerWolters KluwerOcular Rosacea: An Updated Review : Cornea

Escalate promptly for corneal symptoms or signs, including pain, photophobia, reduced vision, keratitis, or corneal neovascularization. Chronic ocular rosacea can progress to corneal scarring and, in severe disease, perforation; ophthalmology evaluation is warranted when corneal involvement is suspected. Wolters KluwerWolters KluwerOcular Rosacea: An Updated Review : Cornea

Elicit patient-specific physiologic and environmental flushing triggers, then advise targeted avoidance when a reproducible association exists. Trigger reduction and appropriate skin care are core components of rosacea management and may improve control of recurrent redness and flushing. Wiley+1WileyRosacea Management: Update on general measures and topical treatment options - Schaller - 2016 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online LibraryPubMedRosacea Management - PMC

Choose topical regimens with attention to cutaneous sensitivity and irritation. Azelaic acid and metronidazole are effective topical choices for inflammatory disease, but tolerability should guide agent selection and continuation. PubMedPubMedRosacea: A Review - PMC

Reassess the phenotype driving residual burden rather than simply cycling therapies. Persistent erythema may remain after papules and pustules improve, and combination treatment is often required when both manifestations are clinically important. WileyWileyRosacea Management: Update on general measures and topical treatment options - Schaller - 2016 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library

For mild to severe papulopustular disease, use topical ivermectin, metronidazole, or azelaic acid as first-line options. Metronidazole and azelaic acid were superior to placebo in papulopustular rosacea; topical ivermectin appeared slightly more effective than topical metronidazole in one study, including participant- and physician-assessed outcomes. Cochrane+1CochraneInterventions for rosacea - van Zuuren, EJ - 2015 | Cochrane Librarybnf nice org ukRosacea | Treatment summaries - BNF - NICE

When topical therapy does not provide adequate control, oral doxycycline is a commonly used next step. Published management algorithms list doxycycline below 50 mg daily after topical therapy, whereas another review describes doxycycline 50 mg once daily or twice daily for disease refractory to topical agents; choose the lowest effective regimen and reassess the need for continued systemic treatment. PubMed+1PubMedRosacea Management - PMCPubMedRosacea: A Review - PMC

For difficult, refractory inflammatory rosacea, oral isotretinoin is an escalation option in published algorithms at 0.5 to 1.0 mg/kg daily. This strategy requires the usual isotretinoin safety infrastructure and is most appropriate when the anticipated benefit justifies systemic risk and monitoring burden. PubMedPubMedRosacea Management - PMC

For persistent erythema, topical brimonidine is an approved treatment option; topical oxymetazoline is also described for periodic flushing, although evidence for vasoactive approaches has been limited. Select an erythema-directed agent when redness remains the principal active concern after controlling inflammatory lesions. Wiley+1WileyRosacea Management: Update on general measures and topical treatment options - Schaller - 2016 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online LibraryPubMedOxymetazoline (Topical): Rosacea - PMC

Use vascular laser or intense pulsed light when telangiectasia or persistent erythema remains clinically significant despite medical management, or when the patient seeks treatment of visible vascular change. These modalities are described as beneficial for erythema and telangiectasia and may also improve burning, stinging, itching, pain, and swelling. Wolters KluwerWolters KluwerUpdate on the Management of Rosacea : Plastic Surgical Nursing

Treat early phymatous inflammatory disease medically when appropriate, but refer established rhinophyma or other fixed phyma for procedural assessment. CO2 laser, dermabrasion, electrocautery, decortication, and surgical approaches are described options for contour correction; procedure choice depends on extent of tissue overgrowth and operator expertise. PubMedPubMedRosacea Management - PMC

Suspect ocular rosacea in chronic blepharitis or dry-eye-like disease accompanied by lid-margin telangiectasia, hyperemia, and meibomian gland dysfunction. The differential includes isolated blepharitis, conjunctivitis, meibomian gland dysfunction, and dry eye syndrome; the characteristic eyelid-margin vascular and inflammatory pattern increases the likelihood of ocular rosacea. Wolters KluwerWolters KluwerOcular Rosacea: An Updated Review : Cornea

Use oral or topical antibacterial therapy as described treatment approaches for ocular symptoms, with oral doxycycline specifically cited for ocular rosacea. Treatment selection should be coordinated with ophthalmology when ocular-surface disease is persistent or when keratitis is present. PubMed+1PubMedRosacea Management - PMCPubMedOxymetazoline (Topical): Rosacea - PMC

Refer for ophthalmologic assessment when examination suggests corneal involvement or when the patient reports visual change, photophobia, or significant ocular pain. Corneal neovascularization and keratitis are the clinically consequential complications because they can progress to scarring and perforation. Wolters KluwerWolters KluwerOcular Rosacea: An Updated Review : Cornea